Guijun Qin Selected Research

Hyperthyroidism

1/2021	Hyperthyroidism Prevalence in China After Universal Salt Iodization.
1/2020	Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guijun Qin Research Topics

Disease

24	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2014
23	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024 - 09/2012
17	Neoplasms (Cancer) 01/2023 - 03/2014
10	Obesity 11/2023 - 03/2014
9	Hypertension (High Blood Pressure) 02/2024 - 05/2018
9	Insulin Resistance 02/2024 - 12/2017
9	Hyperglycemia 10/2021 - 08/2012
8	Prediabetic State (Prediabetes) 01/2023 - 03/2014
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 03/2014
6	Thyroid Neoplasms (Thyroid Cancer) 07/2020 - 08/2015
5	Mitochondrial Diseases (Mitochondrial Disease) 12/2023 - 09/2015
5	Breast Neoplasms (Breast Cancer) 02/2023 - 03/2014
5	Albuminuria 01/2023 - 01/2021
5	Fibrosis (Cirrhosis) 11/2021 - 01/2019
4	Kidney Diseases (Kidney Disease) 01/2024 - 01/2021
4	Diabetes Mellitus 11/2023 - 01/2019
4	Abdominal Obesity 01/2023 - 03/2014
4	Non-alcoholic Fatty Liver Disease 11/2021 - 01/2015
3	Overweight 11/2023 - 01/2021
3	Coronary Disease (Coronary Heart Disease) 01/2023 - 03/2014
3	Chronic Renal Insufficiency 01/2023 - 01/2021
3	Inflammation (Inflammations) 01/2023 - 04/2016
3	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2020
3	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 01/2014
3	Hypogonadism (Hypergonadotropic Hypogonadism) 11/2021 - 01/2019
3	Body Weight (Weight, Body) 01/2021 - 12/2017
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 12/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2024 - 01/2020
2	Cognitive Dysfunction 03/2023 - 01/2021
2	Prehypertension 01/2023 - 01/2022
2	Goiter 12/2021 - 01/2020
2	Hyperthyroidism 01/2021 - 01/2020
2	Graves Disease (Basedow Disease) 01/2021 - 01/2020
2	Myocardial Infarction 01/2021 - 01/2020
2	Proteinuria 01/2021 - 09/2015
2	Thyroid Diseases (Thyroid Disease) 01/2021 - 01/2020
2	Hypothyroidism 12/2020 - 01/2020
2	Hyperuricemia 12/2020 - 08/2020
2	Carcinogenesis 10/2020 - 01/2019
2	Peripheral Nervous System Diseases (PNS Diseases) 06/2019 - 01/2019
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2019 - 01/2017
2	Stomach Neoplasms (Stomach Cancer) 12/2015 - 03/2014

Drug/Important Bio-Agent (IBA)

29	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2013
11	Insulin (Novolin)FDA Link 01/2022 - 12/2010
10	CreatinineIBA 11/2023 - 11/2014
10	AlbuminsIBA 11/2023 - 11/2014
9	Proteins (Proteins, Gene)FDA Link 12/2023 - 07/2015
8	LipidsIBA 01/2023 - 05/2018
8	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2020
7	IodineIBA 12/2021 - 01/2016
6	CholesterolIBA 02/2024 - 03/2014
5	Blood Glucose (Blood Sugar)IBA 01/2024 - 06/2021
5	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
5	LDL CholesterolIBA 01/2022 - 01/2020
5	Long Noncoding RNAIBA 01/2022 - 12/2019
4	SodiumIBA 01/2024 - 01/2016
4	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2021
4	EnzymesIBA 01/2023 - 03/2014
4	HDL CholesterolIBA 01/2022 - 08/2020
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 09/2012
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2021 - 01/2020
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 05/2018
3	Sodium-Glucose Transport ProteinsIBA 11/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2021 - 01/2019
3	ORALIT (ORS)IBA 06/2021 - 01/2020
3	ResveratrolIBA 10/2020 - 09/2012
3	Iodide Peroxidase (Deiodinase)IBA 08/2020 - 01/2020
3	Thyroglobulin FDA Link 08/2020 - 01/2020
3	Cholecalciferol (Vitamin D3)FDA Link 03/2019 - 01/2017
2	CanagliflozinIBA 01/2024 - 12/2023
2	SymportersIBA 01/2024 - 01/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2023 - 01/2022
2	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2023
2	AntioxidantsIBA 11/2023 - 12/2017
2	Indicators and Reagents (Reagents)IBA 01/2023 - 11/2014
2	Hormones (Hormone)IBA 01/2022 - 08/2015
2	Amino Acids FDA Link 01/2022 - 01/2022
2	dapagliflozinIBA 01/2022 - 01/2019
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 05/2014
2	Competitive Endogenous RNAIBA 01/2022 - 12/2019
2	oxidized low density lipoproteinIBA 01/2022 - 08/2020
2	Circular RNAIBA 01/2022 - 01/2022
2	Testosterone (Sustanon)FDA Link 11/2021 - 04/2016
2	Exenatide (Byetta)FDA Link 08/2021 - 01/2021
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 01/2017
2	hydroxide ionIBA 01/2021 - 01/2015
2	CollagenIBA 01/2021 - 12/2019
2	Transforming Growth Factor beta (TGF-beta)IBA 10/2020 - 03/2019
2	Gonadal Steroid Hormones (Sex Hormones)IBA 07/2020 - 01/2019
2	Estrogens (Estrogen)FDA Link 07/2020 - 08/2015
2	Estrogen ReceptorsIBA 07/2020 - 08/2015
2	AntibodiesIBA 01/2020 - 01/2020
2	NAD (NADH)IBA 06/2019 - 01/2019
2	Vitamin D FDA LinkGeneric 04/2016 - 01/2015
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2016 - 10/2015
2	GhrelinIBA 11/2014 - 08/2012

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2016
5	Glycemic Control 11/2021 - 01/2014
2	Intraperitoneal Injections 01/2021 - 01/2019